2005•Unpublished venueRequires access

The effect of atorvastatin on serum C-reactive protein in patients with unstable angina

Deng Ning-xing

Open publisher page 0 citations

Abstract

Objective To evaluate the effect of atorvastatin on serum c-reactive protein in patients with unstable angina. Methods Seventy-six patients were randomly divided into two groups: placebo therapy group and atorvastatin group. All patients would be received outline therapy, and atorvastatin group were administered with additional atorvastatin (10 mg/d) for 8 weeks. Then, serum c-reactive protein and blood lipid were measured just before and after therapy. Results Serum c-reactive protein and lipid levels were significantly reduced in atorvastatin group compared with placebo group (P0.05=. Conclusion Atorvastatin potentiated the decline of serum c-reactive protein and lipid level in patients with unstable angina.

About this research paper

What this paper is about

Objective To evaluate the effect of atorvastatin on serum c-reactive protein in patients with unstable angina. Methods Seventy-six patients were randomly divided into two groups: placebo therapy group and atorvastatin group. All patients would be received outline therapy, and atorvastatin group were administered with additional atorvastatin (10 mg/d) for 8 weeks. Then, serum c-reactive protein and blood lipid were measured just before and after therapy. Results Serum c-reactive protein and lipid levels were significantly reduced in atorvastatin group compared with placebo group (P0.05=. Conclusion Atorvastatin potentiated the decline of serum c-reactive protein and lipid level in patients with unstable angina.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effect of atorvastatin on serum c-reactive protein in patients with unstable angina. Methods Seventy-six patients were randomly divided into two groups: placebo therapy group and atorvastatin group. All patients would be received outline therapy, and atorvastatin group were administered with additional atorvastatin (10 mg/d) for 8 weeks. Then, serum c-reactive protein and blood lipid were measured just before and after therapy. Results Serum c-reactive protein and lipid levels were significantly reduced in atorvastatin group compared with placebo group (P0.05=. Conclusion Atorvastatin potentiated the decline of serum c-reactive protein and lipid level in patients with unstable angina.

Key concepts: Atorvastatin, C-reactive protein, Medicine, Placebo, Stable angina, Unstable angina, Internal medicine, Angina

Related papers

Back to paper searchBrowse research topicsOriginal source
The effect of atorvastatin on serum C-reactive protein in patients with unstable angina — Research Paper | ScholarLens